Morgan Stanley raised the firm’s price target on Globus Medical (GMED) to $83 from $74 and keeps an Equal Weight rating on the shares. The company reported “solid” Q3 topline and bottom-line beats, ...
Globus Medical ( (GMED) ) has released its Q3 earnings. Here is a breakdown of the information Globus Medical presented to its investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback